The CBRC has allowed foreign-invested banks to invest in domestic financial institutions, the CFDA has proposed relaxing drug trial and registration requirements, and the withdrawal procedures for a foreign partner exiting a co-operative joint venture have been eased
Rex Tillerson and President Xi Jinping talked cooperation, China's drug regulator drafted rules to boost entry of new medicines, IBM planned to bring Watson to the local market, and the annual consumer rights show targeted Nike and Muji
The CIRC has required offshore reinsurers to provide security measures, Guangdong has eased corporate operating cost burdens and a plan to make every single ingredient traceable by 2020 was launched
Six key pieces of legislation that would allow the U.S. to confront China if President Trump decides to up the ante—and risk world economic instability